Product Availability


HPS Pharmacies wish to provide information regarding the current worldwide shortages of:

Amoxycillin and Ampicillin Powder for Injection








Late August or early September


500mg, 1g




Late May or early June



500mg, 1g

Unknown – several months


500mg, 1g

Unknown – several months


500mg, 1g



The interruptions to supply of amoxicillin is due to the supply of the active ingredient which has resulted in an unexpected demand for ampicillin. Deliveries are expected according to the dates above, however demand may exceed availability of supplies initially.

HPS Pharmacies are pleased to advise limited stock is currently available for the emergency needs of contracted clients.

Furthermore, ampicillin 1g injection and amoxycillin + clavulanic acid 1g/200mg injection are now available under the Special Access Scheme (SAS) for immediate supply to seriously ill patients, pending completion and forwarding of the Category A SAS form by the medical practitioner. Non urgent supplies require completion of a Category B form, and prior approval by the TGA. SAS supplies of amoxicillin injections are currently under investigation.

These shortages do not currently affect the supply of oral amoxycillin or ampicillin formulations, which will continue to be available.

Should alternative antimicrobials be required, prescribers are advised to select in concordance with the recommendations of the Therapeutic Guidelines: Antibiotic, Version 15.

Please retain this notice in a prominent position, including in other related business units as a reminder for all staff members until supply returns to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter please do not hesitate to contact your pharmacist at HPS Pharmacies.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates